Elevation Oncology, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €7.72K
    Gross profit
    -€7.72K
    SG&A expenses
    €13.91M
    R&D expenses
    €25.28M
    EBITDA
    -€41.07M
    D&A
    €12.01K
    EBIT
    -€42.08M
    Interest expenses
    €933.50K
    EBT
    -€41.14M
    Tax expenses
    €32.60K
    Net income
    -€41.17M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €256.54K
    Changes in working capital
    €3.81M
    Operating cash flow
    -€33.89M
    Capex
    €0.00
    Other investing cash flow
    -€25.27M
    Net investing cash flow
    -€4.55M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €12.48M
    Debt repayment
    €0.00
    Other financing cash flow
    €136.42K
    Net financing cash flow
    €12.59M
    Foreign exchange effects
    €0.00
    Net change in cash
    -€25.86M
    Cash at end of period
    €51.90M
    Free cash flow
    -€33.89M

    Balance sheet

    Cash and cash equivalents
    €51.90M
    Cash and short-term investments
    €69.21M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €1.32M
    Total current assets
    €70.52M
    Property, plant & equipment
    €24.88K
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €0.00
    Total non-current assets
    €24.88K
    Total assets
    €70.55M
    Accounts payable
    €422.14K
    Short-term debt
    €0.00
    Other current liabilities
    €2.79M
    Total current liabilities
    €3.63M
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €26.82M
    Total non-current liabilities
    €26.82M
    Total liabilities
    €30.45M
    Common stock
    €5.15K
    Retained earnings
    -€218.50M
    Other equity
    €9.44K
    Total equity
    €0.00
    Total liabilities and shareholders' equity
    €70.55M

    Company information

    Market capitalization
    €20.05M
    Employees
    34
    Enterprise Value
    -€38.02M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    0.0%
    ROA
    -58.4% Much better than peer group: -1,179.3%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -169.0%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€1.21M

    Notifications